Influenza A Virus A/singapore/gp20238/2024 IVR-277 (H3N2) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: bla
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007786
Compound index — I
490 substances begin with I. 4 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, Influenza A Virus… – Iris Germanica Var….
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Influenza A Virus A/singapore/infimh-16-0019/2016 NIB-104 (H3N2) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007787
Influenza A Virus A/south Australia/55/2014 (H3N2) Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007788
Influenza A Virus A/south Australia/55/2014 (H3N2) Neuraminidase Antigen (mdck Cell Derived, Propiolactone Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007790
Influenza A Virus A/south Australia/55/2014 IVR-175 (H3N2) Neuraminidase Antigen (propiolactone Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007789
Influenza A Virus A/switzerland/6849/2025 (H1N1) Live (attenuated) Antigen US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007793
Influenza A Virus A/switzerland/6849/2025 IVR 278 (H1N1) Antigen (uv, Formaldehyde Inactivated) US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007791
Influenza A Virus A/switzerland/6849/2025 IVR-278 (H1N1) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: bla
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007792
Influenza A Virus A/tasmania/318/2025 CVR-351 (H1N1) Antigen (mdck Cell Derived, Propiolactone Inactivated) US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007794
Influenza A Virus A/tasmania/503/2020 IVR-221 (H3N2) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007795
Influenza A Virus A/tasmania/787/2025 CVR-388 (H3N2) Antigen (mdck Cell Derived, Propiolactone Inactivated) US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007796
Influenza A Virus A/thailand/8/2022 IVR-237 (H3N2) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Allergens [CS]; Blood Coagulation Factor [EPC]
Market presence17 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007797
Influenza A Virus A/thailand/8/2022 IVR-237 (H3N2) Hemagglutinin Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007798
Influenza A Virus A/victoria/2454/2019 IVR-207 (H1N1) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Allergens [CS]; Antimalarial [EPC]; Cell-mediated Immunity [PE]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007799
Influenza A Virus A/victoria/2570/2019 IVR-215 (H1N1) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Actively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]
Market presence27 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007800
Influenza A Virus A/victoria/2570/2019 IVR-215 (H1N1) Hemagglutinin Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007801
Influenza A Virus A/victoria/4897/2022 IVR-238 (H1N1) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: bla
Class as recordedActively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Allergens [CS]; Blood Coagulation Factor [EPC]
Market presence45 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007802
Influenza A Virus A/victoria/4897/2022 IVR-238 (H1N1) Hemagglutinin Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCopper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007803
Influenza A Virus A/victoria/800/2024 CVR-289 (H3N2) Antigen (mdck Cell Derived, Propiolactone Inactivated) US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007804
Influenza A Virus A/vietnam/1203/2004 (H5N1, Clade 1) Hemagglutinin Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Inactivated Influenza A Virus Vaccine [EPC]; Inactivated [CS]; Influenza Vaccines [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007805
Influenza A virus subtype H1N1 haemagglutinin EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007807
Influenza A virus subtype H3N2 haemagglutinin EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007808
Influenza A Virus Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Actively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]
Market presence20 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007809
Influenza A virus/human strain: A/Jena/VI5258/2009 (H1N1)pdm09 EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007806
Influenza B Virus US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]
Market presence37 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007810
Influenza B Virus - B/arizona/21/2025 Antigen (mdck Cell Derived, Propiolactone Inactivated) US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007811
Influenza B Virus B/austria/1359417/2021 BVR-26 Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: bla
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Actively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]
Market presence27 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007812
Influenza B Virus B/austria/1359417/2021 BVR-26 Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Actively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]
Market presence34 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007813
Influenza B Virus B/iowa/06/2017 Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007814
Influenza B Virus B/maryland/15/2016 Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007815
Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: bla
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007816
Influenza B Virus B/michigan/01/2021 Hemagglutinin Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Market presence24 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007817
Influenza B Virus B/pennsylvania/14/2025 Recombinant Hemagglutinin Antigen US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007818
Influenza B Virus B/perth/115/2025 Live (attenuated) Antigen US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007819
Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Actively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]
Market presence32 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007820
Influenza B Virus B/phuket/3073/2013 BVR-1B Antigen (propiolactone Inactivated) US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007821
Influenza B Virus B/phuket/3073/2013 BVR-1B Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Actively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]
Market presence33 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007822
Influenza B Virus B/phuket/3073/2013 Hemagglutinin Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Market presence24 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007823
Influenza B Virus B/phuket/3073/2013 Recombinant Hemagglutinin Antigen US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCopper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007824
Influenza B Virus B/singapore/inftt-16-0610/2016 Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007825
Influenza B Virus B/singapore/wuh4618/2021 Antigen (mdck Cell Derived, Propiolactone Inactivated) US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007826
Influenza B Virus B/tokyo/eis13-175/2025 Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: bla
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007827
Influenza B Virus B/utah/9/2014 Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007828
Influenza B Virus B/utah/9/2014 Neuraminidase Antigen (mdck Cell Derived, Propiolactone Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007829
Influenza B Virus B/washington/02/2019 Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Actively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]
Market presence15 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007830
Influenza B virus Victoria lineage haemagglutinin EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007831
Influenza B Virus Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCopper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007832
Influenza B virus Yamagata lineage haemagglutinin EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007833
influenza vaccine (whole virion, inactivated) containing antigen of: A/Vietnam/1203/2004 (H5N1) EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07BB01
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007834
influenza virus (inactivated, split) of the following strains:A/California/7/2009 (H1N1)pdm09 - like strain (A/California/7/2009, NYMC X-179A)A/Hong Kong/4801/2014 (H3N2) - like strain (A/Hong Kong/4801/2014, NYMC X-263B)B/Brisbane/60/2008 - like strain (B/Brisbane/60/2008, wild type) EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07BB02
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007837
influenza virus (live attenuated) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB01; J07BB03
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007835
Influenza virus A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 strain EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB02
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007836
influenza virus surface antigens EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007838
influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A/Viet Nam/1194/2004 (H5N1) EU-MED Not yet graded
EU medicine: Expired
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007841
Influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/California/7/2009 (H1N1)-derived strain used NYMC X-181 EU-MED Not yet graded
EU medicine: Expired
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007839
influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/turkey/Turkey/1/05 (H5N1)-like strain (NIBRG-23) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007840
Influenza virus surface antigens (haemagglutinin and neuraminidase) of the following strains: A/(H1N1) EU-MED Not yet graded
EU medicine: Opinion
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007842
Influenza virus vaccine CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007843
Influenzinum CA-NHP Not yet graded
CA licensed ingredient
Market presence50 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007844
Ingluvin CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007846
Inland sea water CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007847
Inonotus obliquus CA-NHPEU-NOVEL Not yet graded
Not novel in supplementsCA licensed ingredient
also: Poria obliquua (Fr.) P. Karst. (1881), Fuscoporia obliqua (Fr.) Aoshima, Bull. Tokyo Univ. Forests: 200 (1951), Xanthochrous obliquus (Fr.) Bourdot & Galzin, Hyménomycètes de France: 642 (1928)
Market presence1,125 Canadian licensed products
Parts in scopeFruiting body, and water and ethanol extract thereof (liquid or dried)
Etalyn identifierETA-C-007848
Inonotus Obliquus Fruiting Body US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007849
Inosine US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007850
Inositol CA-NHPEU-CLAIMEU-NOVELUS-DRUG Not yet graded
Not novel in foodEU claims 0 authorised / 2 refusedCA licensed ingredientUS: bulk ingredient
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Analogs/Derivatives [Chemical/Ingredient]
Market presence15 US product listings · 2,152 Canadian licensed products
Parts in scopeMyoinositol; D-chiro-inositol
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Contributes to mental performance Contributes to mental concentration” | Non-authorised | Art.13(1) | EFSA opinion |
| “Important for the function of the nervous system.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-007851
Inositol hexaniacinate CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007852
Inositol hexanicotinate CA-NHP Not yet graded
CA licensed ingredient
Market presence21 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007853
Inositol hexaphosphate CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007854
Inositol niacinate CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007855
Inositol Nicotinate CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007856
Inotuzumab Ozogamicin EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedCD22-directed Antibody Interactions [MoA]; CD22-directed Immunoconjugate [EPC]; Decreased DNA Integrity [PE]; Immunoconjugates [CS]
Earliest US approval2017
Market presence1 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-007858
Insulin CA-NHP Not yet graded
CA licensed ingredient
Market presence27 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007859
Insulin Aspart EU-MEDUS-DRUG Not yet graded
Insulin Aspart Protamine Recombinant US-DRUG Not yet graded
Earliest US approval2001
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007861
Insulin Aspart Recombinant US-DRUG Not yet graded
Earliest US approval2000
Market presence3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007862
Insulin Aspart-Fsan US-DRUG Not yet graded
Earliest US approval2026
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007863
Insulin Aspart-Szjj US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007864
Insulin Aspart-Xjhz US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007865
Insulin Degludec EU-MEDUS-DRUG Not yet graded
Insulin Detemir EU-MEDUS-DRUG Not yet graded
Insulin Detemir Recombinant US-DRUG Not yet graded
Earliest US approval2005
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007868
Insulin Glargine EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: bla
Class as recordedA10AE04; A10AE54; GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]
Earliest US approval2015
Market presence31 US product listings · 3 FDA applications · 7 EU medicines
Etalyn identifierETA-C-007870
Insulin Glargine Recombinant US-DRUG Not yet graded
Earliest US approval2000
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007871
Insulin Glargine-Aglr US-DRUG Not yet graded
Earliest US approval2021
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007872
Insulin Glargine-Aldy US-DRUG Not yet graded
Earliest US approval2026
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007873
Insulin Glargine-Yfgn US-DRUG Not yet graded
Earliest US approval2021
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007874
Insulin Glulisine EU-MEDUS-DRUG Not yet graded
Insulin Glulisine Recombinant US-DRUG Not yet graded
Earliest US approval2004
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007876
Insulin Human EU-MEDUS-DRUG Not yet graded
Insulin Lispro EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: bla
Class as recordedA10AB04; A10AB04;A10AD04; Insulin Analog [EPC]; Insulin [Chemical/Ingredient]
Earliest US approval2017
Market presence54 US product listings · 1 FDA applications · 5 EU medicines
Etalyn identifierETA-C-007879
Insulin Lispro Protamine Recombinant US-DRUG Not yet graded
Earliest US approval1999
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007880
Insulin Lispro Recombinant US-DRUG Not yet graded
Earliest US approval1996
Market presence4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007881
Insulin Lispro-Aabc US-DRUG Not yet graded
Earliest US approval2020
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007882
Insulin Pork US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence16 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007883
Insulin Recombinant Human US-DRUG Not yet graded
Earliest US approval1982
Market presence5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007884
Insulin Susp Isophane Recombinant Human US-DRUG Not yet graded
Earliest US approval1982
Market presence4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007885
Insulin-Like Growth Factor 1 Receptor US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Androgen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007886
Insulin-Like Growth FACTOR-2 US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Androgen Receptor Agonists [MoA]; Androgen [EPC]; Androstanes [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007887
Intercellular Adhesion Molecule 1 US-DRUG Not yet graded
US: unapproved drug other
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007888
Interferon .gamma. Porcine Recombinant US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Antigens; Cell-mediated Immunity [PE]; Corticosteroid Hormone Receptor Agonists [MoA]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007894
Interferon ALFA-N3 US-DRUG Not yet graded
Earliest US approval1989
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007890
interferon alfacon-1 EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedL03AB09
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007891
Interferon BETA-1A EU-MEDUS-DRUG Not yet graded
Interferon BETA-1B EU-MEDUS-DRUG Not yet graded
Interferon GAMMA-1B US-DRUG Not yet graded
US: bla
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]
Earliest US approval1999
Market presence13 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007895
Interleukin-1 .beta. Human US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007896
Interleukin-10 US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Anticholinergic [EPC]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007897
Interleukin-11 US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007898
Interleukin-12 Human Recombinant US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedInterferon gamma [EPC]; Interferon-gamma [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007899
Interleukin-3 US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007900
Interleukin-5 US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007901
Intrinsic Factor CA-NHPUS-DRUG Not yet graded
Inula CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007903
Inula britannica CA-NHP Not yet graded
CA licensed ingredient
Market presence94 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007904
Inula cappa CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007905
Inula helenium CA-NHP Not yet graded
CA licensed ingredient
Market presence76 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007906
Inula Helenium Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Ascorbic Acid [CS]; Cell-mediated Immunity [PE]; Copper [CS]
Market presence11 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007907
Inula Helenium Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCalculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007908
Inula japonica CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007909
Inula racemosa CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007910
Inulin CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved drug other
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Blood Coagulation Factor [EPC]
Earliest US approval1940
Market presence4 US product listings · 1 FDA applications · 1,304 Canadian licensed products
Etalyn identifierETA-C-007911
Inulin / FOS (ß2 ->1 linked fructans) EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “-Inulin (or FOS) promotes healthy gut bacteria or microflora; -Inulin (or FOS) is a prebiotic; -Inulin (or FOS) is bifidogenic; -Inulin (or FOS) promotes good digestive health; -Inulin (or FOS) promotes gastrointestinal /bowel/gut/colonic health; - Prebiotics” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-007912
Inulin / oligofructose / Oligofructose-enriched inulin (specific selection of short & long chains) from chicory EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “-inulin/oligofructose/ oligofructose enriched inulin from chicory stimulates the growth of Bifidobacteria in the colon; -inulin/oligofructose/ oligofructose enriched inulin from chicory beneficially affects the intestinal flora; -inulin/oligofructose/ oligofructose enriched inulin from chicory promote healthy/balanced/good gut bacteria.” | Non-authorised | Art.13(1) | EFSA opinion |
| “-promotes/ supports digestive health -improves bowel regularity; -improves digestive/ bowel function.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-007915
Inulin/oligofructose EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “1) Inulin/oligofructose stimulates the growth of Bifidobacteria in the colon; 2) Beneficially affects the intestinal flora; (3) Prebiotics promote healthy gut bacteria; (4) promotes a healthy bowel function; (5) Promotes better intestinal flora. A better intestinal flora supports your body's defence system; (6) Prebiotic fibres support your natural defence” | Non-authorised | Art.13(1) | EFSA opinion |
| “Inulin/oligofructose enhances calcium absorption” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-007913
Inulin/oligofructose from chicory EU-CLAIM Not yet graded
EU claims 0 authorised / 4 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Inulin/oligofructose help you to feel fuller for longer; Foods with inulin/oligofructose curb your hunger feeling; Foods with inulin/oligofructose make you feel satisfied” | Non-authorised | Art.13(1) | EFSA opinion |
| “inulin/ oligofructose enhances calcium absorption” | Non-authorised | Art.13(1) | EFSA opinion |
| “-inulin/oligofructose from chicory improves intestinal conditions; -inulin/oligofructose fron chicory promotes intestinal health.” | Non-authorised | Art.13(1) | EFSA opinion |
| “inulin/ oligofructose from chicory : - helps to regulate cholesterol level; - contributes to healthy blood cholesterol level; - helps to manage cholesterol level; - helps to maintain healthy blood cholesterol level.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-007914
Invert Sugar US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007916
Invertase CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007917
Iobenguane I-123 US-DRUG Not yet graded
US: nda
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007919
Iobenguane I-131 US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007920
Iobenguane Sulfate US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007918
Iobenguane Sulfate I-123 US-DRUG Not yet graded
Earliest US approval2008
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007921
Iobenguane Sulfate I-131 US-DRUG Not yet graded
Earliest US approval1994
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007922
Iocetamic Acid US-DRUG Not yet graded
Earliest US approval1973
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007923
Iodamide Meglumine US-DRUG Not yet graded
Earliest US approval1978
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007924
Iodargyrite CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007925
Iode CA-NHP Not yet graded
CA licensed ingredient
Market presence45 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007926
Iodine CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 6 authorised / 3 refusedCA licensed ingredientUS: bulk ingredient for human prescription compounding
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence265 US product listings · 5,953 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Iodine contributes to normal cognitive function” | Authorised | Art.13(1) | EFSA opinion |
| “Iodine contributes to normal energy-yielding metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Iodine contributes to normal functioning of the nervous system” | Authorised | Art.13(1) | EFSA opinion |
| “Iodine contributes to the normal growth of children” | Authorised | Art.14(1)(b) | EFSA opinion |
| “Iodine contributes to the maintenance of normal skin” | Authorised | Art.13(1) | EFSA opinion |
| “Iodine contributes to the normal production of thyroid hormones and normal thyroid function” | Authorised | Art.13(1) | EFSA opinion |
| “is important for visual function and eye moisture.” | Non-authorised | Art.13(1) | EFSA opinion |
| “may contribute to preserve healthy hair, nails and skin.” | Non-authorised | Art.13(1) | EFSA opinion |
| “may contribute to preserve healthy hair, nails and skin.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-007927
iodine (131I) omburtamab EU-MED Not yet graded
EU medicine: Refused
Class as recordedV10XA
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007929
Iodine I-131 US-DRUG Not yet graded
US: bulk ingredient for human prescription compounding
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007928
Iodine Povacrylex US-DRUG Not yet graded
US: nda
Earliest US approval2006
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007930
Iodipamide Sodium US-DRUG Not yet graded
Earliest US approval1954
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007931
Iodium CA-NHP Not yet graded
CA licensed ingredient
Market presence66 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007932
Iodixanol US-DRUG Not yet graded
US: anda
Class as recordedRadiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]
Earliest US approval1996
Market presence7 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007933
Iodoformum CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007935
Iodohippurate Sodium I-123 US-DRUG Not yet graded
Earliest US approval1984
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007936
Iodohippurate Sodium I-131 US-DRUG Not yet graded
Earliest US approval1968
Market presence3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007937
Iodoquinol US-DRUG Not yet graded
US: bulk ingredient
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007938
Iodoxamate Meglumine US-DRUG Not yet graded
Earliest US approval1981
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007939
Iodum CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007940
Iodure de potassium CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007941
Iofetamine Hydrochloride I-123 US-DRUG Not yet graded
Earliest US approval1987
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007942
ioflupane (123l) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedV09AB03
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007943
Ioflupane I-123 US-DRUG Not yet graded
US: anda
Class as recordedRadioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
Earliest US approval2011
Market presence2 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007944
Iohexol US-DRUG Not yet graded
US: anda
Class as recordedRadiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]
Earliest US approval1985
Market presence21 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007945
Iomeprol US-DRUG Not yet graded
US: bulk ingredient
Class as recordedRadiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]
Earliest US approval2024
Market presence17 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007946
Iopamidol US-DRUG Not yet graded
US: anda
Class as recordedRadiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]
Earliest US approval1985
Market presence21 US product listings · 14 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007947
Iopanoic Acid US-DRUG Not yet graded
Earliest US approval1951
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007948
Iophendylate US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007949
Iopromide US-DRUG Not yet graded
US: nda
Class as recordedRadiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]
Earliest US approval1995
Market presence4 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007950
Iota-Carrageenan CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007951
Iothalamate Sodium US-DRUG Not yet graded
US: nda
Class as recordedRadiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]
Earliest US approval1962
Market presence2 US product listings · 7 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007952
Iothalamate Sodium I-125 US-DRUG Not yet graded
US: nda
Class as recordedRadioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
Earliest US approval1974
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007953
Iothalamic Acid US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007954
Iotrolan US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007955
Ioversol US-DRUG Not yet graded
US: bulk ingredient
Class as recordedRadiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]
Earliest US approval1988
Market presence10 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007956
Ioxaglate Sodium US-DRUG Not yet graded
Earliest US approval1985
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007957
Ioxilan US-DRUG Not yet graded
Earliest US approval1995
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007958
Ipamorelin US-DRUG Not yet graded
US: bulk ingredient
Market presence11 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007959
Ipeca CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007960
Ipecac CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAcidifying Activity [MoA]; Actively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Adrenergic alpha-Agonists [MoA]
Market presence225 US product listings · 1 Canadian licensed products
Etalyn identifierETA-C-007961
Ipecacuanha CA-NHP Not yet graded
CA licensed ingredient
Market presence150 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007962
Ipilimumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedCTLA-4-directed Antibody Interactions [MoA]; CTLA-4-directed Blocking Antibody [EPC]; Increased T Lymphocyte Activation [PE]; L01FX04
Earliest US approval2011
Market presence7 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-007963
Ipodate Sodium US-DRUG Not yet graded
Earliest US approval1962
Market presence3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007964
Ipomoea aquatica EU-NOVEL Not yet graded
Not novel in food
Parts in scopeLeaves and Stem
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-007965
Ipomoea hederacea EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-007967
Ipomoea nil CA-NHP Not yet graded
CA licensed ingredient
Market presence30 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007968
Ipomoea purga CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007969
Ipomoea Purga Root US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007970
Ipomoea purpurea CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007971
Ipomoea Purpurea TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Fruit Proteins [EXT]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007972
Ipragliflozin L-Proline US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007973
Ipratropium Bromide US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic beta2-Agonists [MoA]; Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; beta2-Adrenergic Agonist [EPC]
Earliest US approval1986
Market presence67 US product listings · 45 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007974
Iptacopan Hydrochloride EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedComplement Factor B Inhibitor [EPC]; Complement Factor B Inhibitors [MoA]; L04A
Earliest US approval2023
Market presence4 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-007975
Irbesartan EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, ExpiredUS: anda
Class as recordedAngiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; C09CA04; C09DA04
Earliest US approval1997
Market presence140 US product listings · 42 FDA applications · 12 EU medicines
Etalyn identifierETA-C-007976
Irbesartan: Hydrochlorothiazide US-DRUG Not yet graded
Earliest US approval2012
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007977
Iridium US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Antigens
Market presence34 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007978
irinotecan anhydrous free-base EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01CE02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007980
Irinotecan Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedTopoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
Earliest US approval1996
Market presence41 US product listings · 29 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007979
Iris domestica CA-NHP Not yet graded
CA licensed ingredient
Market presence59 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007981
Iris florentina CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007982
Iris germanica CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007983
Iris Germanica Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedBlood Coagulation Factor [EPC]; Calcium [CS]; Cations; Divalent [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007984
Iris Germanica Var. Florentina Root US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Bismuth [CS]; Bismuth [EPC]; Blood Coagulation Factor [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007985